Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 2,589.45
+52.45 (2.07%)
At close: Jul 7, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 14.27 billion as of July 7, 2026. Its market cap has increased by 262.78% in one year.
Market Cap
14.27B
Enterprise Value
16.05B
Revenue
6.35B
Ranking
n/a
PE Ratio
42.29
Stock Price
2,589.45
Market Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.41M to 14.27B, an increase of 48,445.60%. That is a compound annual growth rate of 82.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 14.27B | 91.55% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 22.25B |
| Amrutanjan Health Care | 15.36B |
| Shukra Pharmaceuticals | 14.53B |
| Syncom Formulations (India) | 13.15B |
| TTK Healthcare | 13.02B |
| Lincoln Pharmaceuticals | 12.30B |
| Fermenta Biotech | 11.63B |
| Wanbury | 9.92B |